UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine

Annals of the rheumatic diseases, 2020-06, Vol.79 (6), p.837

2020

Link zum Volltext

Verfügbarkeit prüfen

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

Annals of the rheumatic diseases, 2019-06, Vol.78 (6), p.736

2019

Link zum Volltext

Verfügbarkeit prüfen

Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus

The Journal of clinical investigation, 2019-03, Vol.129 (3), p.1359-1371

2019

Link zum Volltext

Verfügbarkeit prüfen

An Autoimmunogenic and Proinflammatory Profile Defined by the Gut Microbiota of Patients With Untreated Systemic Lupus Erythematosus

Arthritis & rheumatology (Hoboken, N.J.), 2021-02, Vol.73 (2), p.232-243

2021

Link zum Volltext

Verfügbarkeit prüfen

A Review of Neutrophil Extracellular Traps (NETs) in Disease: Potential Anti-NETs Therapeutics

Clinical reviews in allergy & immunology, 2021-10, Vol.61 (2), p.194-211

2021

Link zum Volltext

Verfügbarkeit prüfen

EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome

Annals of the rheumatic diseases, 2017-03, Vol.76 (3), p.476

2017

Link zum Volltext

Verfügbarkeit prüfen

Trial of Anifrolumab in Active Systemic Lupus Erythematosus

The New England journal of medicine, 2020-01, Vol.382 (3), p.211-221

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus

Nature communications, 2021-06, Vol.12 (1), p.3391-11, Article 3391

2021

Link zum Volltext

Verfügbarkeit prüfen

First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus )-Pan-American League of Associations of Rheumatology (PANLAR)

Annals of the rheumatic diseases, 2018-11, Vol.77 (11), p.1549

2018

Link zum Volltext

Verfügbarkeit prüfen

Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study

Annals of the rheumatic diseases, 2016-11, Vol.75 (11), p.1909-1916

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study

Annals of the rheumatic diseases, 2020-12, Vol.79 (12), p.1544

2020

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases

Annals of the rheumatic diseases, 2020-09, Vol.79 (9), p.1170

2020

Link zum Volltext

Verfügbarkeit prüfen

VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease

Science (American Association for the Advancement of Science), 2019-12, Vol.366 (6472), p.1531-1536

2019

Link zum Volltext

Verfügbarkeit prüfen

Medication Nonadherence in Systemic Lupus Erythematosus: A Systematic Review

Arthritis care & research (2010), 2017-11, Vol.69 (11), p.1706-1713

2017

Link zum Volltext

Verfügbarkeit prüfen

Dehydroepiandrosterone for systemic lupus erythematosus

Cochrane database of systematic reviews, 2007-10 (4), p.CD005114

2007

Link zum Volltext

Verfügbarkeit prüfen

Phase II randomised trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritis

Annals of the rheumatic diseases, 2022-04, Vol.81 (4), p.496

2022

Link zum Volltext

Verfügbarkeit prüfen

BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus

Annals of the rheumatic diseases, 2022-04, Vol.81 (4), p.575

2022

Link zum Volltext

Verfügbarkeit prüfen

Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus

Nature medicine, 2016-09, Vol.22 (9), p.991-993

2016

Link zum Volltext

Verfügbarkeit prüfen

Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19

Annals of the rheumatic diseases, 2020-10, Vol.79 (10), p.1386

2020

Link zum Volltext

Verfügbarkeit prüfen

One year in review 2017: systemic lupus erythematosus

Clinical and experimental rheumatology, 2017-07, Vol.35 (4), p.551

2017

Link zum Volltext

Verfügbarkeit prüfen

Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE

Lupus, 2013-01, Vol.22 (1), p.63-72

2013

Link zum Volltext

Verfügbarkeit prüfen

Antinuclear Antibody–Negative Systemic Lupus Erythematosus in an International Inception Cohort

Arthritis care & research (2010), 2019-07, Vol.71 (7), p.893-902

2019

Link zum Volltext

Verfügbarkeit prüfen

Systemic lupus erythematosus

The Lancet (British edition), 2014-11, Vol.384 (9957), p.1878-1888

2014

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models

The Journal of immunology (1950), 2019-05, Vol.202 (10), p.2888-2906

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 13.501

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(11.223)
Mit Volltextzugriff
(8.926)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(12.455)
Science & Technology
(9.879)
Life Sciences & Biomedicine
(9.754)
Lupus Erythematosus, Systemic - Drug Therapy
(8.714)
Female
(8.350)
Adult
(5.846)
Systemic Lupus Erythematosus
(5.339)
Rheumatology
(4.655)
Male
(4.480)
Lupus Erythematosus, Systemic - Complications
(4.401)
Middle Aged
(3.762)
Lupus
(3.083)
Lupus Erythematosus, Systemic - Immunology
(2.311)
Immunosuppressive Agents - Therapeutic Use
(2.197)
Biological And Medical Sciences
(2.137)
Adolescent
(2.134)
Medical Sciences
(2.114)
Lupus Erythematosus, Systemic - Diagnosis
(2.007)
Treatment Outcome
(1.939)
General & Internal Medicine
(1.404)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Journals@Ovid
(5.939)
EZB Free E-Journals
(4.582)
Ingenta
(4.425)
Single Journals
(2.569)
IngentaConnect Journals
(1.812)
SpringerLink Journals (MCLS)
(1.703)
Elsevier ScienceDirect Journals Complete
(1.627)
Wiley Online Library Journals
(1.545)
Wiley Online Library
(1.388)
SAGE Complete
(1.214)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(1.085)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(942)
British Medical Journals Online Archive (BMJ)
(735)
Oxford Journals Online Current
(711)
Taylor & Francis Journals Complete
(442)
BMJ Journals Archiv - DFG Nationallizenzen
(422)
Oxford Journals 2020 Medicine
(411)
Nexis
(278)
Springer Nature - Connect here FIRST to enable access
(238)
Factiva
(167)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Lupus
(1.072)
Journal Of Rheumatology
(472)
Annals Of The Rheumatic Diseases
(365)
Arthritis And Rheumatism
(356)
Rheumatology
(300)
Clinical Rheumatology
(288)
Clinical And Experimental Rheumatology
(203)
Rheumatology International
(199)
Arthritis Research & Therapy
(122)
Seminars In Arthritis And Rheumatism
(118)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus

An Autoimmunogenic and Proinflammatory Profile Defined by the Gut Microbiota of Patients With Untreated Systemic Lupus Erythematosus

A Review of Neutrophil Extracellular Traps (NETs) in Disease: Potential Anti-NETs Therapeutics

EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome

Trial of Anifrolumab in Active Systemic Lupus Erythematosus

Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus

First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus )-Pan-American League of Associations of Rheumatology (PANLAR)

Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study

Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study

Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases

VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease

Medication Nonadherence in Systemic Lupus Erythematosus: A Systematic Review

Dehydroepiandrosterone for systemic lupus erythematosus

Phase II randomised trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritis

BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus

Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus

Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19

One year in review 2017: systemic lupus erythematosus

Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE

Antinuclear Antibody–Negative Systemic Lupus Erythematosus in an International Inception Cohort

Systemic lupus erythematosus

Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models

Suchergebnisse filtern